Your browser version may not work well with NCBI's Web applications. More information here...

Recent Activity

Items 1 - 20 of 106
of 6Next
1:
Ichim TE, Zhong Z, Kaushal S, Zheng X, Ren X, Hao X, Joyce JA, Hanley HH, Riordan NH, Koropatnick J, Bogin V, Minev BR, Min WP, Tullis RH.
Free in PMC
Exosomes as a tumor immune escape mechanism: possible therapeutic implications.
J Transl Med. 2008 Jul 22;6:37.
PMID: 18644158 [PubMed - indexed for MEDLINE]
2:
Abusamra AJ, Zhong Z, Zheng X, Li M, Ichim TE, Chin JL, Min WP.
Abstract
Tumor exosomes expressing Fas ligand mediate CD8+ T-cell apoptosis.
Blood Cells Mol Dis. 2005 Sep-Oct;35(2):169-73.
PMID: 16081306 [PubMed - indexed for MEDLINE]
3:
Huber V, Fais S, Iero M, Lugini L, Canese P, Squarcina P, Zaccheddu A, Colone M, Arancia G, Gentile M, Seregni E, Valenti R, Ballabio G, Belli F, Leo E, Parmiani G, Rivoltini L.
Abstract
Human colorectal cancer cells induce T-cell death through release of proapoptotic microvesicles: role in immune escape.
Gastroenterology. 2005 Jun;128(7):1796-804.
PMID: 15940614 [PubMed - indexed for MEDLINE]
4:
Greil R, Egle A, Villunger A.
Abstract
On the role and significance of Fas (Apo-1/CD95) ligand (FasL) expression in immune privileged tissues and cancer cells using multiple myeloma as a model.
Leuk Lymphoma. 1998 Nov;31(5-6):477-90. Review.
PMID: 9922038 [PubMed - indexed for MEDLINE]
5:
Igney FH, Krammer PH.
Abstract
Tumor counterattack: fact or fiction?
Cancer Immunol Immunother. 2005 Nov;54(11):1127-36. Epub 2005 May 12. Review.
PMID: 15889255 [PubMed - indexed for MEDLINE]
6:
Seliger B.
Abstract
Strategies of tumor immune evasion.
BioDrugs. 2005;19(6):347-54. Review.
PMID: 16392887 [PubMed - indexed for MEDLINE]
7:
Quah BJ, O'Neill HC.
Abstract
The immunogenicity of dendritic cell-derived exosomes.
Blood Cells Mol Dis. 2005 Sep-Oct;35(2):94-110.
PMID: 15975838 [PubMed - indexed for MEDLINE]
8:
Dong H, Strome SE, Salomao DR, Tamura H, Hirano F, Flies DB, Roche PC, Lu J, Zhu G, Tamada K, Lennon VA, Celis E, Chen L.
Abstract
Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion.
Nat Med. 2002 Aug;8(8):793-800. Epub 2002 Jun 24. Erratum in: Nat Med 2002 Sep;8(9):1039.
PMID: 12091876 [PubMed - indexed for MEDLINE]
9:
Ichikawa M, Chen L.
Abstract
Role of B7-H1 and B7-H4 molecules in down-regulating effector phase of T-cell immunity: novel cancer escaping mechanisms.
Front Biosci. 2005 Sep 1;10:2856-60.
PMID: 15970540 [PubMed - indexed for MEDLINE]
10:
Malmberg KJ.
Abstract
Effective immunotherapy against cancer: a question of overcoming immune suppression and immune escape?
Cancer Immunol Immunother. 2004 Oct;53(10):879-92. Epub 2004 Jul 28. Review.
PMID: 15338206 [PubMed - indexed for MEDLINE]
11:
Abrahams VM, Kamsteeg M, Mor G.
Abstract
The Fas/Fas ligand system and cancer: immune privilege and apoptosis.
Mol Biotechnol. 2003 Sep;25(1):19-30. Review.
PMID: 13679631 [PubMed - indexed for MEDLINE]
12:
Bennett MW, O'connell J, O'sullivan GC, Roche D, Brady C, Kelly J, Collins JK, Shanahan F.
Free in PMC
Expression of Fas ligand by human gastric adenocarcinomas: a potential mechanism of immune escape in stomach cancer.
Gut. 1999 Feb;44(2):156-62.
PMID: 9895372 [PubMed - indexed for MEDLINE]
13:
Chaput N, Schartz NE, Andre F, Zitvogel L.
Abstract
Exosomes for immunotherapy of cancer.
Adv Exp Med Biol. 2003;532:215-21. Review.
PMID: 12908560 [PubMed - indexed for MEDLINE]
14:
Abrams SI.
Abstract
Positive and negative consequences of Fas/Fas ligand interactions in the antitumor response.
Front Biosci. 2005 Jan 1;10:809-21. Print 2005 Jan 1. Review.
PMID: 15569621 [PubMed - indexed for MEDLINE]
15:
Yoshizawa H, Kagamu H, Gejyo F.
Abstract
Cancer immunogene therapy.
Arch Immunol Ther Exp (Warsz). 2001;49(5):337-43. Review.
PMID: 11798131 [PubMed - indexed for MEDLINE]
16:
Clayton A, Tabi Z.
Abstract
Exosomes and the MICA-NKG2D system in cancer.
Blood Cells Mol Dis. 2005 May-Jun;34(3):206-13.
PMID: 15885603 [PubMed - indexed for MEDLINE]
17:
Bodey B, Bodey B Jr, Siegel SE, Kaiser HE.
Abstract
Fas (Apo-1, CD95) receptor expression in childhood astrocytomas. Is it a marker of the major apoptotic pathway or a signaling receptor for immune escape of neoplastic cells?
In Vivo. 1999 Jul-Aug;13(4):357-73.
PMID: 10586378 [PubMed - indexed for MEDLINE]
18:
Ioannides CG, Whiteside TL.
Abstract
T cell recognition of human tumors: implications for molecular immunotherapy of cancer.
Clin Immunol Immunopathol. 1993 Feb;66(2):91-106. Review.
PMID: 8453790 [PubMed - indexed for MEDLINE]
19:
Li XB, Zhang ZR, Schluesener HJ, Xu SQ.
Free Full Text
Role of exosomes in immune regulation.
J Cell Mol Med. 2006 Apr-Jun;10(2):364-75. Review.
PMID: 16796805 [PubMed - indexed for MEDLINE]
20:
Stremmel C, Klein P, Hohenberger W.
Abstract
[Immune tolerance and active suppression in oncology. Immunological principles and therapeutic options]
Chirurg. 2002 Mar;73(3):255-61. Review. German.
PMID: 11963500 [PubMed - indexed for MEDLINE]
Items 1 - 20 of 106
of 6Next